Back to results
CompletedPhase 3

Open-Label Access Protocol of Denosumab for Subjects With Advanced Cancer

NCT01419717

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Research Site

Capital Federal, Buenos Aires, Argentina

+63 additional locations

View on ClinicalTrials.gov
Open-Label Access Protocol of Denosumab for Subjects With Advanced Cancer — TrialFind